BTW
EW icon

Boston Trust Walden’s Edwards Lifesciences EW Stock Holding History

Boston Trust Walden’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$23.3M Sell
257,222
-25,728
-9% -$2.16M 0.18% 170
2026
Q1 		$22.7M Buy
282,950
+16,045
+6% +$1.32M 0.19% 170
2025
Q4 		$22.8M Sell
266,905
-8,171
-3% -$671K 0.17% 176
2025
Q3 		$21.4M Sell
275,076
-2,015
-0.7% -$157K 0.16% 174
2025
Q2 		$21.7M Sell
277,091
-2,811
-1% -$210K 0.15% 169
2025
Q1 		$20.3M Sell
279,902
-2,470
-0.9% -$177K 0.15% 178
2024
Q4 		$20.9M Buy
282,372
+132,629
+89% +$9.28M 0.15% 176
2024
Q3 		$9.88M Buy
149,743
+40
+0% +$2.91K 0.07% 205
2024
Q2 		$13.8M Hold
149,703
– – 0.1% 182
2024
Q1 		$14.3M Hold
149,703
– – 0.1% 182
2023
Q4 		$11.4M Sell
149,703
-2,212
-1% -$154K 0.09% 185
2023
Q3 		$10.5M Sell
151,915
-700
-0.5% -$56.3K 0.09% 189
2023
Q2 		$14.4M Sell
152,615
-1,111
-0.7% -$96.6K 0.12% 181
2023
Q1 		$12.7M Sell
153,726
-890
-0.6% -$70K 0.11% 186
2022
Q4 		$11.5M Sell
154,616
-736
-0.5% -$56.7K 0.1% 193
2022
Q3 		$12.8M Sell
155,352
-10,940
-7% -$1.05M 0.13% 187
2022
Q2 		$15.8M Sell
166,292
-526
-0.3% -$54.5K 0.15% 183
2022
Q1 		$19.6M Sell
166,818
-17,510
-9% -$1.96M 0.16% 173
2021
Q4 		$23.9M Sell
184,328
-5,000
-3% -$583K 0.19% 166
2021
Q3 		$21.4M Buy
189,328
+819
+0.4% +$93.5K 0.19% 166
2021
Q2 		$19.5M Sell
188,509
-7,200
-4% -$679K 0.17% 168
2021
Q1 		$16.4M Sell
195,709
-19,445
-9% -$1.64M 0.16% 180
2020
Q4 		$19.6M Sell
215,154
-800
-0.4% -$66.4K 0.21% 153
2020
Q3 		$17.2M Sell
215,954
-802
-0.4% -$62.6K 0.21% 149
2020
Q2 		$15M Sell
216,756
-7,275
-3% -$517K 0.2% 161
2020
Q1 		$14.1M Sell
224,031
-23,304
-9% -$1.68M 0.22% 139
2019
Q4 		$19.2M Sell
247,335
-573
-0.2% -$44.7K 0.22% 142
2019
Q3 		$18.2M Sell
247,908
-2,100
-0.8% -$148K 0.23% 137
2019
Q2 		$15.4M Sell
250,008
-693
-0.3% -$41.9K 0.2% 148
2019
Q1 		$16M Hold
250,701
– – 0.22% 138
2018
Q4 		$12.8M Sell
250,701
-11,748
-4% -$594K 0.2% 147
2018
Q3 		$15.2M Hold
262,449
– – 0.21% 134
2018
Q2 		$12.7M Sell
262,449
-1,860
-0.7% -$86.8K 0.19% 156
2018
Q1 		$12.3M Sell
264,309
-15,600
-6% -$677K 0.19% 155
2017
Q4 		$10.5M Sell
279,909
-2,541
-0.9% -$93.3K 0.15% 177
2017
Q3 		$10.3M Hold
282,450
– – 0.16% 178
2017
Q2 		$11.1M Hold
282,450
– – 0.18% 161
2017
Q1 		$8.86M Hold
282,450
– – 0.14% 187
2016
Q4 		$8.82M Sell
282,450
-23,100
-8% -$748K 0.14% 184
2016
Q3 		$12.3M Sell
305,550
-900
-0.3% -$33.9K 0.2% 163
2016
Q2 		$10.2M Sell
306,450
-300
-0.1% -$10.3K 0.17% 171
2016
Q1 		$9.02M Hold
306,750
– – 0.16% 183
2015
Q4 		$8.08M Sell
306,750
-4,650
-1% -$121K 0.15% 189
2015
Q3 		$7.38M Sell
311,400
-300
-0.1% -$7.24K 0.12% 208
2015
Q2 		$7.4M Hold
311,700
– – 0.11% 203
2015
Q1 		$7.4M Sell
311,700
-13,800
-4% -$310K 0.11% 196
2014
Q4 		$6.91M Sell
325,500
-18,900
-5% -$380K 0.1% 197
2014
Q3 		$5.86M Sell
344,400
-867,330
-72% -$13.7M 0.09% 200
2014
Q2 		$17.3M Sell
1,211,730
-44,040
-4% -$597K 0.25% 153
2014
Q1 		$15.5M Buy
1,255,770
+63,600
+5% +$734K 0.23% 157
2013
Q4 		$13.1M Sell
1,192,170
-344,040
-22% -$3.88M 0.19% 167
2013
Q3 		$17.8M Buy
1,536,210
+486,810
+46% +$5.7M 0.27% 147
2013
Q2 		$11.8M Buy
+1,049,400
New +$12.4M 0.19% 166

Other funds holding EW

Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
WT
Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return
BHIA
Birch Hill Investment Advisors Boston, Massachusetts $2.47B AUM 20.95% 1-Year Est. Return
NONA
Ninety One North America New York $2.13B AUM 9.16% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
SIM
Seilern Investment Management London, United Kingdom $794M AUM 6.63% 1-Year Est. Return

Boston Trust Walden's EW Position: Q2 2026 in Review

Boston Trust Walden reduced its Edwards Lifesciences (EW) stake by 9.1% in Q2 2026, selling an estimated $2.16M and leaving 257,222 shares worth $23.3M. The position accounts for 0.18% of the portfolio, ranked #170.

Boston Trust Walden first reported a position in EW in Q2 2013 and has held it in 53 quarters since. The position peaked at $23.9M in Q4 2021. 518 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Boston Trust Walden held 257,222 shares of Edwards Lifesciences worth $23.3M as of Q2 2026.
  • Boston Trust Walden sold 25,728 Edwards Lifesciences shares in Q2 2026, an estimated $2.16M.
  • Edwards Lifesciences made up 0.18% of Boston Trust Walden's portfolio in Q2 2026, its #170 holding.
  • Boston Trust Walden first reported a position in Edwards Lifesciences in Q2 2013 and has held it in 53 quarters since.
  • Boston Trust Walden's Edwards Lifesciences position peaked at $23.9M in Q4 2021.
  • 518 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Boston Trust Walden's 13F filing for Q2 2026, filed 24 Jul 2026.